To Increase Patient Access
End Brain Cancer Mobile App to download your number one tool for navigating this disease.

July 8, 2023

rGBM Study: Share Your Experience and Shape Future Treatments for GBM

Are you or a loved one living with Glioblastoma (GBM)? Have you experienced a recurrence? If so, you are invited to contribute to an important rGBM study by participating in a short interview.

The first step is a 5-minute phone or Zoom pre-qualification interview conducted by EBCI staff. Simply click the button below to fill out the form or call us at 425-444-2215 to let us know you are interested and we will reach out to schedule this short pre-qualification interview.

For those who qualify, the next step is a joint patient and caregiver interview. In this interview, participants will have the opportunity to share their experiences living with recurrent GBM. Participating caregivers will also be asked to complete a survey following the interview. By providing your valuable perspectives and insights, you will help to shape future treatments for GBM.

Eligible individuals with recurrent GBM and caregivers who complete the joint interview will receive one $100 Visa gift card. Caregivers will also receive one $50 Visa gift card for completing the post-interview survey.

The joint 45-minute interview can be scheduled at your convenience, typically within business hours. Interviews will be conducted virtually or by phone by Adelphi Values, a research company that works with pharmaceutical companies and patient advocacy organizations to understand various health conditions.

Click the button below to learn more about this rGBM study and see if you qualify.


Enhancing patient outcomes by expanding FDA-approved treatment modalities and fueling research in the pharma/bio/life sciences, device & diagnostic industries and by closing the existing GAP from initial diagnosis to IMMEDIATE AND EXPANDED ACCESS to specialists, researchers, advanced & innovative treatments, clinical trials and critical care with the ultimate goal of improving patient outcomes through updating and improving WHO & NCCN Guidelines and clinical practices related to Standard of Care for brain cancer patients.

TAX ID:26-2185614
corporate partners
upcoming events
About us
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram